PUBLISHER: KBV Research | PRODUCT CODE: 1472512
PUBLISHER: KBV Research | PRODUCT CODE: 1472512
Europe Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others), By Country and Growth Forecast, 2024 - 2031
The Europe Inhalation Capsules Market would witness market growth of 5.5% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $83.5 Million by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.3% during (2024 - 2031).
Inhalation capsules, also known as dry powder inhalers (DPIs), are devices used to deliver medication directly into the lungs as a dry powder. Typically employed to treat respiratory conditions, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma, these capsules contain a powdered formulation of the medication. As per the World Health Organization (WHO), COPD accounted for around 6% of all deaths in 2019 and ranks as the third leading cause of death. In addition, lower respiratory infections remained the deadliest communicable disease, ranked as the 4th leading cause of death.
Additionally, the inhalation mode of drug delivery entails the patient passing their breath through the apparatus, which subsequently distributes the powdered medication into the pulmonary system for absorption into the bloodstream. The purpose of inhalation capsules is to deliver medication to the respiratory system in a targeted and efficient manner. This method provides several benefits, including improved patient compliance, a quicker onset of action, and decreased systemic side effects.
Several factors drive the growth of the inhalation capsules market in various European nations. Countries like Germany, France, Italy, and the United Kingdom are witnessing significant growth in the inhalation capsules market due to the aging population, environmental factors, and lifestyle changes contributing to the rise in respiratory disorders. Thus, all these factors will boost the regional market's expansion in the coming years.
Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Cipla Limited
- Novartis AG
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Lonza Group Ltd. (Capsugel)
- Chiesi Farmaceutici S.p.A
- Vectura Group Plc (Philip Morris International, Inc.)
- Elpen S.A.
- Healthcaps India Ltd.
- Qualicaps Co., LTD. (Roquette Freres SA)
Europe Inhalation Capsules Market Report Segmentation
By Type
- Gelatin Capsules
- Hypromellose Capsules
By Application
- Asthma Treatment
- COPD Management
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Europe Inhalation Capsules Market, by Type
- 1.4.2Europe Inhalation Capsules Market, by Application
- 1.4.3Europe Inhalation Capsules Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.Recent Strategies Deployed in Inhalation Capsules Market
Chapter 5.Europe Inhalation Capsules Market by Type
- 5.1Europe Gelatin Capsules Market by Country
- 5.2Europe Hypromellose Capsules Market by Country
Chapter 6.Europe Inhalation Capsules Market by Application
- 6.1Europe Asthma Treatment Market by Country
- 6.2Europe COPD Management Market by Country
- 6.3Europe Others Market by Country
Chapter 7.Europe Inhalation Capsules Market by Country
- 7.1Germany Inhalation Capsules Market
- 7.1.1Germany Inhalation Capsules Market by Type
- 7.1.2Germany Inhalation Capsules Market by Application
- 7.2UK Inhalation Capsules Market
- 7.2.1UK Inhalation Capsules Market by Type
- 7.2.2UK Inhalation Capsules Market by Application
- 7.3France Inhalation Capsules Market
- 7.3.1France Inhalation Capsules Market by Type
- 7.3.2France Inhalation Capsules Market by Application
- 7.4Russia Inhalation Capsules Market
- 7.4.1Russia Inhalation Capsules Market by Type
- 7.4.2Russia Inhalation Capsules Market by Application
- 7.5Spain Inhalation Capsules Market
- 7.5.1Spain Inhalation Capsules Market by Type
- 7.5.2Spain Inhalation Capsules Market by Application
- 7.6Italy Inhalation Capsules Market
- 7.6.1Italy Inhalation Capsules Market by Type
- 7.6.2Italy Inhalation Capsules Market by Application
- 7.7Rest of Europe Inhalation Capsules Market
- 7.7.1Rest of Europe Inhalation Capsules Market by Type
- 7.7.2Rest of Europe Inhalation Capsules Market by Application
Chapter 8.Company Profiles
- 8.1Cipla Limited
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
- 8.2Novartis AG
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expense
- 8.2.5Recent strategies and developments:
- 8.2.5.1Trials and Approvals:
- 8.2.6SWOT Analysis
- 8.3AstraZeneca PLC
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5Recent strategies and developments:
- 8.3.5.1Partnerships, Collaborations, and Agreements:
- 8.3.5.2Trials and Approvals:
- 8.3.6SWOT Analysis
- 8.4Boehringer Ingelheim International GmbH
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional & Segmental Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
- 8.5Lonza Group Ltd. (Capsugel)
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
- 8.6Chiesi Farmaceutici S.p.A
- 8.6.1Company Overview
- 8.6.2Recent strategies and developments:
- 8.6.2.1Partnerships, Collaborations, and Agreements:
- 8.6.2.2Product Launches and Product Expansions:
- 8.6.3SWOT Analysis
- 8.7Vectura Group plc (Philip Morris International, Inc.)
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expenses
- 8.7.5Recent strategies and developments:
- 8.7.5.1Partnerships, Collaborations, and Agreements:
- 8.7.5.2Geographical Expansions:
- 8.7.6SWOT Analysis
- 8.8Elpen S.A.
- 8.8.1Company Overview
- 8.8.2SWOT Analysis
- 8.9Healthcaps India Ltd.
- 8.9.1Company Overview
- 8.9.2SWOT Analysis
- 8.10.Qualicaps Co., LTD. (Roquette Freres SA)
- 8.10.1Company Overview
- 8.10.2SWOT Analysis
LIST OF TABLES
- TABLE 1Europe Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 2Europe Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 3Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 4Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 5Europe Gelatin Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 6Europe Gelatin Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 7Europe Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 8Europe Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 9Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 10Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 11Europe Asthma Treatment Market by Country, 2020 - 2023, USD Million
- TABLE 12Europe Asthma Treatment Market by Country, 2024 - 2031, USD Million
- TABLE 13Europe COPD Management Market by Country, 2020 - 2023, USD Million
- TABLE 14Europe COPD Management Market by Country, 2024 - 2031, USD Million
- TABLE 15Europe Others Market by Country, 2020 - 2023, USD Million
- TABLE 16Europe Others Market by Country, 2024 - 2031, USD Million
- TABLE 17Europe Inhalation Capsules Market by Country, 2020 - 2023, USD Million
- TABLE 18Europe Inhalation Capsules Market by Country, 2024 - 2031, USD Million
- TABLE 19Germany Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 20Germany Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 21Germany Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 22Germany Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 23Germany Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 24Germany Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 25UK Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 26UK Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 27UK Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 28UK Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 29UK Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 30UK Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 31France Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 32France Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 33France Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 34France Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 35France Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 36France Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 37Russia Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 38Russia Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 39Russia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 40Russia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 41Russia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 42Russia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 43Spain Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 44Spain Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 45Spain Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 46Spain Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 47Spain Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 48Spain Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 49Italy Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 50Italy Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 51Italy Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 52Italy Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 53Italy Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 54Italy Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 55Rest of Europe Inhalation Capsules Market, 2020 - 2023, USD Million
- TABLE 56Rest of Europe Inhalation Capsules Market, 2024 - 2031, USD Million
- TABLE 57Rest of Europe Inhalation Capsules Market by Type, 2020 - 2023, USD Million
- TABLE 58Rest of Europe Inhalation Capsules Market by Type, 2024 - 2031, USD Million
- TABLE 59Rest of Europe Inhalation Capsules Market by Application, 2020 - 2023, USD Million
- TABLE 60Rest of Europe Inhalation Capsules Market by Application, 2024 - 2031, USD Million
- TABLE 61Key Information - Cipla Limited
- TABLE 62Key Information - Novartis AG
- TABLE 63Key Information - AstraZeneca PLC
- TABLE 64Key Information - Boehringer Ingelheim International GmbH
- TABLE 65Key Information -Lonza Group Ltd.
- TABLE 66Key Information - Chiesi Farmaceutici S.p.A
- TABLE 67Key Information - Vectura Group plc
- TABLE 68Key Information - Elpen S.A.
- TABLE 69Key Information - Healthcaps India Ltd.
- TABLE 70Key Information - Qualicaps Co., LTD.
